Find Grants

Search results

• Finished

  CCNE: Project 1/Schaeffer

  Schaeffer, A. J., Mirkin, C. A. & Rademaker, A. W.

  National Cancer Institute

  9/30/05 → 8/31/10

  Project: Research project

• Evaluation of Predictive Signatures of Prostate Cancer

  Lee, C., Catalona, W. J. & Yang, X. J.

  University of California, Irvine, National Cancer Institute

  9/30/05 → 6/30/10

  Project: Research project

• A Community-Based Healthy Lifestyles Partnership

  Weiss, K. B., Feinglass, J. M. & Wolf, M.

  National Institute on Minority Health and Health Disparities

  9/30/05 → 12/29/08

  Project: Research project

• Adolescent Diet, Hormones & Breast Cancer Susceptibility

  Van Horn, L.

  Fox Chase Cancer Center, National Cancer Institute

  9/30/05 → 6/30/10

  Project: Research project

• CCNE: Project 3/Dravid

  Dravid, V. P.

  National Cancer Institute

  9/30/05 → 8/31/10

  Project: Research project

• Center of Excellence in Translational Human Stem Cell Research - Administrative Core

  Kessler, J., Goldman, R., Hendrix, M. J. C., Lowe Jr, W. L., Meade, T. J., Seftor, R. E. B. & Stupp, S.

  National Institute of Neurological Disorders and Stroke

  9/30/05 → 8/31/10

  Project: Research project

• CCNE: Project 1/Schink

  Mirkin, C. A. & Rademaker, A. W.

  National Cancer Institute

  9/30/05 → 8/31/10

  Project: Research project

• CCNE: Project 6/Stupp

  Stupp, S.

  National Cancer Institute

  9/30/05 → 8/31/10

  Project: Research project

• CCNE: Project 2/Mrksich

  Mirkin, C. A.

  National Cancer Institute

  9/30/05 → 8/31/10

  Project: Research project

• Diversity Supplement: C.Elegans Model for Neurodegenerative Diseases of Aging

  Morimoto, R. I.

  National Institute on Aging

  9/30/05 → 6/30/10

  Project: Research project

• CCNE: Project 1/Woodruff

  Woodruff, T. K.

  National Cancer Institute

  9/30/05 → 8/31/10

  Project: Research project

• Characterization of TiO2-based Photoactive Materials

  Gray, K. A.

  UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy

  9/30/05 → 8/31/06

  Project: Research project

• Center of Excellence in Translational Human Stem Cell Research - Project 1

  Goldman, R. & Shumaker, D. K.

  National Institute of Neurological Disorders and Stroke

  9/30/05 → 8/31/10

  Project: Research project

• CCNE: Project 6/Scheidt

  Scheidt, K. A.

  National Cancer Institute

  9/30/05 → 8/31/10

  Project: Research project

• CCNE Project 3/Meade

  Meade, T. J.

  National Cancer Institute

  9/30/05 → 8/31/10

  Project: Research project

• Prot# 20050111: An Open-Label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects with Plaque Psoriasis

  Paller, A.

  Immunex Corporation

  9/29/05 → 12/31/17

  Project: Research project

• Interdisciplinary Palliative Care Education Program

  Paice, J.

  Rush University Medical Center, National Cancer Institute

  9/29/05 → 8/31/10

  Project: Research project

• Visible/Short Wavelength Photon Counting Arrays (PCAR)

  Mohseni, H.

  Defense Advanced Research Projects Agency (DARPA)

  9/28/05 → 12/31/09

  Project: Research project

• Transcriptional Regulation of NC Precursor Formation

  LaBonne, C.

  National Cancer Institute

  9/26/05 → 7/31/12

  Project: Research project

• Prot# A0081066: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Pregabalin Versus Placebo in the Treatment of Neuropathic Pain Associated with HIV Neuropathy

  Cohen, B. A.

  PPD Development, Pfizer Inc.

  9/26/05 → 9/30/08

  Project: Research project

• q-Modulated Magnetic Resonance Contrast Agents

  Meade, T. J.

  National Institute of Biomedical Imaging and Bioengineering

  9/23/05 → 1/31/10

  Project: Research project

• Prot# AVF2562s: Phase II Trial of Bevacizumab in Combination with FOLFIRI Chemotherapy as First-Line Therapy of Colorectal Cancer: The BAFIL (Bevacizumab and 5-FU, Irinotecan, Leucovorin) Trial (NU Prot# NU V04I8)

  Mulcahy, M. F.

  Genentech, Inc.

  9/23/05 → 9/30/09

  Project: Research project

• Prot# XRP9881B-3001: Randomized, Open-Label, Phase III Study of RPR109881 IV Every 3 Weeks vs Capecitabine (Xeloda®) Tablets Twice Daily for 2 Weeks in 3-Week Cycles in Patients w/ Metastatic Breast Cancer Progressing after Taxanes & Anthracycli

  Gradishar, W. J.

  Pharmaceutical Product Development, LLC, Aventis Pharmaceuticals Inc.

  9/23/05 → 11/20/08

  Project: Research project

• Prot# Hx-CD4-110: Opn-Lbl, Dose-Esclt'n, Followed by Dbl-Bld, Rndmzd, 2-Dose, Prl'l Grp, MltCtr Clin'l Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Pts w/ Mycosis Fungoides Type CTCL (stage IB-IVB) who are Refractory or Intolerant to

  Kuzel, T. M.

  Genmab, Inc.

  9/23/05 → 11/20/08

  Project: Research project

• Prot# WA18062: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Reduction of Signs and Symptoms During Treatment with MRA vs. Placebo, in Combination with Methotrexate in Patients with Moderate to Sever

  Ruderman, E. M.

  Hoffman-La Roche, Inc.

  9/23/05 → 9/11/10

  Project: Research project